Search clinical trials for: KRAS, HRAS, or NRAS Mutations
Total 206172 results
-
Institute of Cancer Research, United KingdomCancer Research UKTerminated
-
University of California, San FranciscoTerminatedALK Fusion Protein Expression | Stage III Cutaneous Melanoma | Stage IIIA Cutaneous Melanoma | Stage IIIB Cutaneous Melanoma | Stage IIIC Cutaneous Melanoma | Stage IV Cutaneous Melanoma | ROS1 Fusion Positive | BRAF wt Allele | Invasive Skin Melanoma | MET Fusion Gene Positive | NRAS wt Allele | NTRK1 Fusion... and other conditionsUnited States
-
Brugmann University HospitalCompleted
-
M.D. Anderson Cancer CenterUnknownKidney Cancer | Colorectal Cancer | Bladder Cancer | Skin Cancer | Endometrial Cancer | Uterus CancerUnited States
-
Allist Pharmaceuticals, Inc.UnknownLocally Advanced or Metastatic EGFR Sensitising Mutation Positive Non-small Cell Lung CancerChina
-
City of Hope Medical CenterNational Cancer Institute (NCI)Completed
-
National Institute on Deafness and Other Communication...Terminated
-
National Institute of Diabetes and Digestive and...CompletedDiabetes Mellitus | Insulin Resistance | Abnormal Glucose MetabolismUnited States
-
Samsung Medical CenterCompletedBenign Prostatic HyperplasiaKorea, Republic of
-
Memorial Sloan Kettering Cancer CenterCompletedBreast Cancer | Ovarian CancerUnited States
-
Novartis PharmaceuticalsWithdrawn
-
National Cancer Institute (NCI)CompletedNon-Small-Cell Lung CarcinomaUnited States, Mexico, Bolivia, Peru, Venezuela
-
Eloxx Pharmaceuticals, Inc.TerminatedGenetic Diseases | Nonsense Mutations
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedIntraocular Retinoblastoma | Recurrent Retinoblastoma | Extraocular RetinoblastomaUnited States, Canada, Puerto Rico
-
Scripps HealthJ. Craig Venter InstituteCompletedLi-Fraumeni Syndrome | Hereditary Cancer Syndromes | TP53 Gene Germline Mutation CarrierUnited States
-
Region Örebro CountyTerminated
-
Assistance Publique - Hôpitaux de ParisCompletedNeonatal Diabetes Secondary to Mutation in the Potassium ChannelFrance
-
Novartis PharmaceuticalsTerminatedMyelofibrosis With High Molecular Risk MutationsBelgium, Spain, United Kingdom, Hungary, Italy, Japan, Taiwan, Germany, Canada, Singapore, Austria, Australia, France, Israel, Sweden, Switzerland, Hong Kong, Greece, Turkey, Brazil, Russian Federation, Denmark, Portugal, Norway, Poland
-
Novartis PharmaceuticalsTerminatedAdvanced Non Small Cell Lung Cancer (NSCLC)France, Italy, Taiwan, Spain, Netherlands, Japan, Hong Kong, Korea, Republic of, Norway, United States, United Kingdom, Poland
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | BRCA1 Mutation Carrier | BRCA2 Mutation Carrier | Ovarian Epithelial TumorUnited States
-
University of Alabama at BirminghamCompletedCystic FibrosisUnited States
-
Novartis PharmaceuticalsCompletedTumors With CDK4/6 Pathway ActivationUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Ovarian Carcinoma | Recurrent Head and Neck Carcinoma | Recurrent Renal Cell Carcinoma | Stage III Renal Cell Cancer | Endometrial Carcinoma | Stage III Bladder Cancer | Cervical Squamous Cell Carcinoma | Stage IV Breast Cancer | Malignant Uterine Neoplasm | Recurrent Bladder Carcinoma | Recurrent... and other conditionsUnited States
-
M.D. Anderson Cancer CenterTerminated
-
Samsung Medical CenterCompletedGastric CancerKorea, Republic of
-
MedImmune LLCCompletedMelanomaItaly, United States, Canada, France
-
Cancer Institute and Hospital, Chinese Academy...QuestgenomicsUnknownRecurrent or Metastatic Breast CancerChina
-
Hoffmann-La RocheCompletedStudy of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid TumorsSolid TumorsUnited States
-
Spirita Oncology, LLCTerminatedAML | MDS | CMMLUnited States
-
Astellas Pharma Global Development, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC)United States, Australia, Belgium, Canada, Chile, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Peru, Portugal, Romania, Russian Federation, Singapore, Spain, Taiwan, Thailand, Ukraine, United Kingdom
-
Cerenis Therapeutics, SATerminatedFamilial HypoalphalipoproteinemiaFrance, United States, Belgium, Canada, Israel, Italy, Netherlands
-
Bhavana BhatnagarCTI BioPharmaCompletedRecurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Therapy-Related Acute Myeloid LeukemiaUnited States
-
Placon TherapeuticsUnknownBreast Neoplasms | Prostatic Neoplasms | Pancreatic Neoplasms | Ovarian NeoplasmsUnited States
-
Yonsei UniversityUnknownCompletely Resected NSCLC With Common EGFR MutationsKorea, Republic of
-
AHMED ABDULQADER HAMMOUDA ABOU SHALLAssiut University; Kuwait UniversityUnknown
-
Massachusetts General HospitalDana-Farber Cancer Institute; Genentech, Inc.CompletedNon-small Cell Lung CancerUnited States
-
Shanghai Jiao Tong University School of MedicineRenJi Hospital; Huashan Hospital; Ruijin Hospital; Eastern Hepatobiliary Surgery...UnknownGallbladder Cancer | Cholangiocarcinoma of the Extrahepatic Bile DuctChina
-
University of FloridaDriverWithdrawn
-
Lei LiUnknownEpithelial Ovarian Cancer | Progression-free Survival | Epithelial Ovarian Tumor of Borderline Malignancy | Driving MutationsChina
-
Allife Medical Science and Technology Co., Ltd.Unknown
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerPortugal
-
University of California, DavisEli Lilly and CompanyCompletedLung Cancer | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Cancer Institute and Hospital, Chinese Academy...PfizerEnrolling by invitation
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)Terminated
-
Asan Medical CenterUnknownCancer | Lung Cancer Metastatic | ImmunotherapyKorea, Republic of
-
Washington University School of MedicineCompletedSolid Tumor | Solid MalignancyUnited States
-
National Institute of Neurological Disorders and...CompletedVon Hippel-Lindau DiseaseUnited States
-
Astellas Pharma Global Development, Inc.No longer availableAcute Myeloid Leukemia (AML) | FMS-like Tyrosine Kinase-3 (FLT3) MutationsAustralia, Italy, United Kingdom
-
University of RochesterCompletedDental Caries | Restorative MaterialUnited States